LivaNova

6500 Wedgwood Road North

Maple Grove, MN 55311

763.220.4110

IMPORTANT SAFETY INFORMATION

Disclaimer: Individual results may vary. This information is designed to help you learn more about TMVR. It is intended to provide you with helpful information but, is for information purposes only, is not medical advice and should not be used as an alternative to speaking with your doctor. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information, please speak to your healthcare professional. Limited by federal law to investigational use in the United States, Canada and Europe. Not for sale in United States, Canada or Europe. For use by clinical investigators only. Related information on the study can be found at www.clinicaltrials.gov using identifier NCT02768402. Trademarks may be registered and are the property of their respective owners. Copyright 2017 LivaNova, Inc. All rights reserved.

INTRODUCING

An investigational
non-surgical
treatment for
MITRAL REGURGITATION
(MR)

DO YOU HAVE MITRAL REGURGITATION (MR)?

If your doctor has told you that you have mitral regurgitation (MR), also called mitral insufficiency or mitral incompetence, you have come to the right place. Medications alone are not enough for many patients suffering with MR, and oftentimes MR patients are not good candidates for surgery for a variety of reasons. If you’re one of these patients, you may qualify for a clinical trial studying an investigational device for MR.

‚Äč

This website provides useful information about the LivaNova Caisson Transcatheter Mitral Valve Replacement (TMVR) clinical trial to help you determine if it’s right for you.

WHAT IS MITRAL

REGURGITATION?

TREATMENT

OPTIONS

CLINICAL TRIAL ELIGIBILITY

1. Lloyd-Jones D, Adams RJ, Brown TM, et al; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.

2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368(9540):1005-1011.